|
|
|
|
|
|
|
Minerva Neuroscie (NERV)
|
|
7.2 0.05 (0.7%)
|
04-20 16:00
|
|
Open:
|
7.05
|
Pre. Close:
|
7.15
|
|
High:
|
7.35
|
Low:
|
6.9
|
|
Volume:
|
92,248
|
Market Cap:
|
279M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
7.358 - 7.388
|
7.388 - 7.413
|
|
Low:
|
6.823 - 6.857
|
6.857 - 6.887
|
|
Close:
|
7.139 - 7.197
|
7.197 - 7.247
|
|
|
|
Technical analysis (as of: 2018-04-20 4:32:06 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 8.94 One year: 10.44
|
|
Support:
|
Support1: 6.57 Support2: 5.90
|
|
Resistance:
|
Resistance1:
7.65 Resistance2: 8.94
|
|
Pivot:
|
6.93 
|
|
Moving Averages:
|
MA(5): 7.14 MA(20): 6.78
MA(100): 6.10 MA(250): 6.85
|
|
MACD:
|
MACD(12,26):
0.27  Signal(12,26,9): 0.26
|
|
%K %D:
|
%K(14,3): 73.75 %D(3): 72.43
|
|
RSI:
|
RSI(14): 60.75
|
|
52-Week:
|
High: 11.15
Low: 4.801 Change(%): 6.7
|
|
Average Vol(K):
|
3-Month: 15994
10-Days 11862
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.NERV has closed below upper band by 26.9%. Bollinger Bands are 9.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-04-10T08:00:00-04:00
Your Daily Pharma Scoop: Acadia Sell-Off, Therapix Soars On Results, Menlo Setback
2018-04-09T10:16:51-04:00
Minerva commences mid-stage study of MIN-117 in MDD; shares up 2%
2018-03-26T15:40:52-04:00
Minerva Neurosciences (NERV) Negative Symptoms of Schizophrenia - Slideshow
2018-03-12T11:56:06-04:00
Minerva Neurosciences' (NERV) CEO Remy Luthringer on Q4 2017 Results - Earnings Call Transcript
2018-03-11T18:30:40-04:00
Notable earnings before Monday's open
2018-02-14T01:53:25-05:00
Minerva: Get Ahead Of The Rush?
2017-11-29T12:47:29-05:00
Midday Gainers / Losers
2017-11-27T13:48:19-05:00
Acadia Pharmaceuticals: The Harmony Trial And Buyout Potential
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
